Howard S Hochster MD
@hshochstermd.bsky.social
👉Associate Cancer Center Director for Clinical Research
Rutgers Cancer Institute
👉Director GI Oncology,Medical Oncologist
👉Distinguished Professor of Medicine
Rutgers RWJ School of
👉cancer researcher, clinician, clinical trialist
Rutgers Cancer Institute
👉Director GI Oncology,Medical Oncologist
👉Distinguished Professor of Medicine
Rutgers RWJ School of
👉cancer researcher, clinician, clinical trialist
Love ❤️ the @rutgerscancer.bsky.social @rwjbarnabashealth.bsky.social booth at #ASCO25. Great job team!
June 1, 2025 at 5:07 PM
Love ❤️ the @rutgerscancer.bsky.social @rwjbarnabashealth.bsky.social booth at #ASCO25. Great job team!
At ribbon cutting for #MorrisCancerCenter: NJ Gov @PhilMurphy with Jack Morris, @slibutti, NJ Assembly speaker @CraigCoughlinNJ and @rutgersupress.bsky.social Pres Holloway. Latest in reseach and patient care @rutgerscancer.bsky.social
May 13, 2025 at 7:24 PM
At ribbon cutting for #MorrisCancerCenter: NJ Gov @PhilMurphy with Jack Morris, @slibutti, NJ Assembly speaker @CraigCoughlinNJ and @rutgersupress.bsky.social Pres Holloway. Latest in reseach and patient care @rutgerscancer.bsky.social
Coming 5/13 - official dedication (see it on livestream) and outpatient visits beginning 5/19/25.
👉See you there 👈@rutgerscancer.bsky.social
👉See you there 👈@rutgerscancer.bsky.social
#MondaysAtTheMorris
The Jack & Sheryl Morris Cancer Center is an integrated smart building with an efficiency-driven design and will be home to four linear accelerators and diagnostic radiology.
cinj.org/TheMorris
@rutgerscancer.bsky.social
@rwjbarnabashealth.bsky.social
The Jack & Sheryl Morris Cancer Center is an integrated smart building with an efficiency-driven design and will be home to four linear accelerators and diagnostic radiology.
cinj.org/TheMorris
@rutgerscancer.bsky.social
@rwjbarnabashealth.bsky.social
April 27, 2025 at 1:26 PM
Coming 5/13 - official dedication (see it on livestream) and outpatient visits beginning 5/19/25.
👉See you there 👈@rutgerscancer.bsky.social
👉See you there 👈@rutgerscancer.bsky.social
Reposted by Howard S Hochster MD
Steven Libutti tells us about building a $900 million cancer hospital for @rutgerscancer.bsky.social/@rwjbarnabashealth.bsky.social
https://cancerletter.com/conversation-with-the-cancer-letter/20250425_1
https://cancerletter.com/conversation-with-the-cancer-letter/20250425_1
Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health - The Cancer Letter
Over the past seven years, as Steven K. Libutti was designing the 12-story, $900-plus million cancer hospital in New Brunswick, NJ, he often thought of the functionality of the building that inspired it: Building 10, the NIH Clinical Center. To access this subscriber-only content please log in or subscribe.If your institution has a site license, […]
cancerletter.com
April 25, 2025 at 9:41 PM
Steven Libutti tells us about building a $900 million cancer hospital for @rutgerscancer.bsky.social/@rwjbarnabashealth.bsky.social
https://cancerletter.com/conversation-with-the-cancer-letter/20250425_1
https://cancerletter.com/conversation-with-the-cancer-letter/20250425_1
And, founding Director of @rutgerscancer.bsky.social ! Congrats Bill. We are proud of you.
Congratulations to William N. Hait, MD, PhD, FAACR, who will be honored with the 2025 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research during the AACR Annual Meeting 2025. Learn more: www.aacr.org/about-the-aa... #AACR25 #AACRFellows
April 8, 2025 at 5:02 PM
And, founding Director of @rutgerscancer.bsky.social ! Congrats Bill. We are proud of you.
So pleased to join @SyedAAhmad5 & the @SWOG1505 co-authors on important publication of a prospective peri-operative #pancreaticcancer NCTN trial. 👉Greater Chemo dose delivery correlates w/ improved survival👈. @RutgersCancer @RWJBarnabas
acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
Chemotherapy dose density is prognostic for overall survival in patients with resectable pancreas cancer: A landmark analysis of SWOG 1505
Higher chemotherapy dose density is associated with improved overall survival in patients with resectable pancreatic adenocarcinoma receiving perioperative chemotherapy.
acsjournals.onlinelibrary.wiley.com
February 14, 2025 at 12:49 AM
So pleased to join @SyedAAhmad5 & the @SWOG1505 co-authors on important publication of a prospective peri-operative #pancreaticcancer NCTN trial. 👉Greater Chemo dose delivery correlates w/ improved survival👈. @RutgersCancer @RWJBarnabas
acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
Now accruing 49% minority patients @rutgerscancer.bsky.social. Check this out !
@rutgerscancer.bsky.social @rwjbarnabashealth.bsky.social experts Dr. Coral Omene and Dr. Mariam Eskander address best practices for boosting the enrollment of underserved populations in cancer clinical trials in Cancer Network.
www.cancernetwork.com/view/best-pr...
www.cancernetwork.com/view/best-pr...
Best Practices for Boosting the Enrollment of Underserved Populations in Cancer Clinical Trials
Coral Omene, MD, PhD, and Mariam Eskander, MD, MPH, discuss how to continue engagement in clinical trial enrollment for underserved populations.
www.cancernetwork.com
February 4, 2025 at 7:14 PM
Now accruing 49% minority patients @rutgerscancer.bsky.social. Check this out !
#GI25. Important subgroup analysis of C80702 adjuvant study. CtDNA+ patients after surgery can benefit from celecoxib. Amazing result. Thanks to the whole team. Latest trials @rutgerscancer.bsky.social
CtDNA blood test may help plan treatment and predict prognosis for patients with stage III #ColonCancer. Read a plain language summary of the research from #GI25
ASCO Gastrointestinal Cancers Symposium - Research Summaries for Patients
Visit this page during the meeting to find patient-friendly summaries of highlighted research.
society.asco.org
January 25, 2025 at 11:26 PM
#GI25. Important subgroup analysis of C80702 adjuvant study. CtDNA+ patients after surgery can benefit from celecoxib. Amazing result. Thanks to the whole team. Latest trials @rutgerscancer.bsky.social
👉Practice changing study! #GI25 Thanks Scott and colleagues. Get latest trials @rutgerscancer.bsky.social @rwjbarnabashealth.bsky.social
New research just presented at #GI25: BREAKWATER study finds 1L EC + mFOLFOX6 improves outcomes in BRAFV600E-mutant mCRC, offering new SOC: brnw.ch/21wQfxm
#ASCODailyNews #GICSM
#ASCODailyNews #GICSM
January 25, 2025 at 11:23 PM
👉Practice changing study! #GI25 Thanks Scott and colleagues. Get latest trials @rutgerscancer.bsky.social @rwjbarnabashealth.bsky.social
Innovative biomarker driven trial in neoadjuvant Rx of #gastriccancer. Thanks to PIs Dr Tim Kennedy and Dr Salma Jabbour @rutgerscancer.bsky.social @rwjbarnabashealth.bsky.social . Presented at #GI25. Thanks to all involved in this outstanding work and Merck for support.
January 25, 2025 at 1:36 AM
Innovative biomarker driven trial in neoadjuvant Rx of #gastriccancer. Thanks to PIs Dr Tim Kennedy and Dr Salma Jabbour @rutgerscancer.bsky.social @rwjbarnabashealth.bsky.social . Presented at #GI25. Thanks to all involved in this outstanding work and Merck for support.
Interesting phase 3 data on intraperitoneal therapy from China #GI25. Soon to be studied in @eaonc.bsky.social STOPGAP study. At @rutgerscancer.bsky.social lead by Dr Brett Ecker
January 23, 2025 at 11:19 PM
Interesting phase 3 data on intraperitoneal therapy from China #GI25. Soon to be studied in @eaonc.bsky.social STOPGAP study. At @rutgerscancer.bsky.social lead by Dr Brett Ecker
Great message in these times. Thanks Dr K. #GI25
Live now: Our keynote @pamelakunzmd.bsky.social discussing the impact of workplace diversity and health equity on access to trials, diagnostic testing, and the role of physicians as advocates.
#GI25
#GI25
January 23, 2025 at 9:43 PM
Great message in these times. Thanks Dr K. #GI25